文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

A群和W135群脑膜炎球菌联合外膜囊泡可激活细胞介导的免疫反应以及针对非共价结合荚膜多糖A的长期记忆反应。

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

作者信息

Romeu Belkis, Lastre Miriam, García Luis, Cedré Bárbara, Mandariote Aleida, Fariñas Mildrey, Oliva Reynaldo, Rosenqvist Einar, Pérez Oliver

机构信息

Immunology Department, Vice presidency of Research and Development, Havana, Cuba,

出版信息

Immunol Res. 2014 Jan;58(1):75-85. doi: 10.1007/s12026-013-8427-6.


DOI:10.1007/s12026-013-8427-6
PMID:23660844
Abstract

Outer-membrane vesicles (OMVs) have inherent adjuvant properties, and many vaccines use OMV as vaccine components. Utilizing the adjuvant properties of OMV could lead to the formulation of vaccines that are less expensive and potentially more immunogenic than covalently conjugated polysaccharide vaccines. We evaluated the adjuvant effect in Balb/c mice of combinations of OMV from Neisseria meningitidis serogroup A and W135 as compared to that of the non-covalently conjugated capsular polysaccharide A. Both antigens were adsorbed onto aluminum hydroxide. The mice were given a booster dose of plain polysaccharide A to stimulate an immunologic memory response. Subclasses determination and cytokine assays demonstrated the capacity of OMV to induce a IgG2a/IgG2b isotype profile and IFN-γ production, suggesting the induction of a Th1 pattern immune response. Lymphoproliferative responses to OMVs were high, with affinity maturation of antibodies observed. Bactericidal titers after the booster dose were also observed. Memory B cells and long-term memory T cells were also detected. The results of this study indicate that combined meningococcal serogroup A and W135 OMV can activate cell-mediated immunity and induce a long-term memory response.

摘要

外膜囊泡(OMV)具有内在的佐剂特性,许多疫苗使用OMV作为疫苗成分。利用OMV的佐剂特性可能会开发出比共价结合多糖疫苗更便宜且可能更具免疫原性的疫苗。我们评估了来自A群和W135群脑膜炎奈瑟菌的OMV组合在Balb/c小鼠中的佐剂效果,并与非共价结合的荚膜多糖A进行了比较。两种抗原均吸附于氢氧化铝上。给小鼠接种一剂普通多糖A加强针以刺激免疫记忆反应。亚类测定和细胞因子检测表明,OMV能够诱导IgG2a/IgG2b同型谱和IFN-γ产生,提示诱导了Th1型免疫反应。对OMV的淋巴细胞增殖反应较高,观察到抗体亲和力成熟。加强针接种后的杀菌效价也被观察到。还检测到记忆B细胞和长期记忆T细胞。本研究结果表明,A群和W135群脑膜炎球菌联合OMV可激活细胞介导的免疫并诱导长期记忆反应。

相似文献

[1]
Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

Immunol Res. 2014-1

[2]
Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.

APMIS. 2016-11

[3]
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.

Vaccine. 2013-10-10

[4]
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

Vaccine. 2005-5-31

[5]
An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.

Scand J Immunol. 2012-8

[6]
Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.

Curr Microbiol. 2009-9-23

[7]
Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.

Vaccine. 2014-11-20

[8]
Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory.

Immunol Invest. 2022-10

[9]
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.

Vaccine. 2004-6-2

[10]
Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.

Paediatr Drugs. 2012-2-1

引用本文的文献

[1]
Microbial Extracellular Vesicles in Host-Microbiota Interactions.

Results Probl Cell Differ. 2024

[2]
Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities.

Imeta. 2023-2-6

[3]
Hybrid response to SARS-CoV-2 and C after an OMV-adjuvanted immunization in mice and their offspring.

Hum Vaccin Immunother. 2024-12-31

[4]
Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.

Appl Microbiol Biotechnol. 2024-2-24

[5]
Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application.

Biomed Res Int. 2021

[6]
Pathogenesis Mediated by Bacterial Membrane Vesicles.

Subcell Biochem. 2021

[7]
Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant .

Front Microbiol. 2019-6-18

[8]
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.

Front Microbiol. 2018-4-26

[9]
Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Sci Rep. 2018-1-30

[10]
The Therapeutic Benefit of Bacterial Membrane Vesicles.

Int J Mol Sci. 2017-6-16

本文引用的文献

[1]
Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.

Mucosal Immunol. 2012-7-18

[2]
An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.

Scand J Immunol. 2012-8

[3]
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.

PLoS One. 2012-2-8

[4]
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.

Nat Med. 2011-11-20

[5]
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.

Eur J Pharm Sci. 2011-6-15

[6]
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.

Scand J Infect Dis. 2011-10

[7]
Immunologic considerations for generating memory CD8 T cells through vaccination.

Cell Microbiol. 2011-4-28

[8]
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.

Expert Rev Vaccines. 2011-3

[9]
Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine.

J Infect Dis. 2010-8-15

[10]
Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination.

Vaccine. 2010-1-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索